Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Our proprietary pan-amyloid removal (PAR) therapeutics are designed to directly bind to and remove toxic amyloid in organs and tissues. By targeting the universal disease-causing pathology in all systemic amyloidosis diseases, PAR therapeutics have the potential to treat and reverse disease in patients with all types and stages of systemic amyloidosis.
View Top Employees from AttralusWebsite | https://www.attralus.com/ |
Employees | 31 (23 on RocketReach) |
Address | 50 Francisco St Suite 450, San Francisco, California 94133, US |
Industry | Biotechnology Research |
Looking for a particular Attralus employee's phone or email?
Spencer Guthrie is the CEO of Attralus.
23 people are employed at Attralus.
Attralus is based in San Francisco, California.